Syapse is disrupting healthcare by bringing omics into routine medical use. Built on a powerful cloud-based semantic data platform, Syapse applications enable the generation and use of omics profiles in diagnosing and treating patients at diagnostic companies, research institutions, medical centers, and payers. Led by an experienced, multidisciplinary team of entrepreneurs, software developers, and scientists, Syapse was founded at Stanford University and is backed by The Social+Capital Partnership.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 01/22/13 | undisclosed | Series A |
Social+Capital Partnership | undisclosed |
| 07/10/14 | $10,000,000 | Series B |
Social+Capital Partnership | undisclosed |
| 11/14/17 | $30,000,000 | Series D |
Amgen Business Development Ascension Health Ventures GE Ventures Intermountain Healthcare Medidata Solutions Merck Global Health Innovation Fund Roche Venture Fund Safeguard Scientifics Social Capital | undisclosed |
